|
1
|
A microRNA expression signature of human solid tumors defines cancer gene targets.
|
Proc Natl Acad Sci U S A
|
2006
|
40.09
|
|
2
|
MicroRNA gene expression deregulation in human breast cancer.
|
Cancer Res
|
2005
|
27.56
|
|
3
|
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.
|
N Engl J Med
|
2005
|
26.02
|
|
4
|
miR-15 and miR-16 induce apoptosis by targeting BCL2.
|
Proc Natl Acad Sci U S A
|
2005
|
21.51
|
|
5
|
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias.
|
Proc Natl Acad Sci U S A
|
2004
|
14.59
|
|
6
|
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues.
|
Proc Natl Acad Sci U S A
|
2004
|
13.66
|
|
7
|
A microRNA signature of hypoxia.
|
Mol Cell Biol
|
2006
|
7.24
|
|
8
|
Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas.
|
Cancer Cell
|
2007
|
5.40
|
|
9
|
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.
|
Cancer Res
|
2007
|
5.40
|
|
10
|
Micro-RNA profiling in kidney and bladder cancers.
|
Urol Oncol
|
2007
|
4.35
|
|
11
|
MiR-15a and miR-16-1 cluster functions in human leukemia.
|
Proc Natl Acad Sci U S A
|
2008
|
4.33
|
|
12
|
Familial cancer associated with a polymorphism in ARLTS1.
|
N Engl J Med
|
2005
|
3.35
|
|
13
|
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer.
|
Genome Res
|
2013
|
2.57
|
|
14
|
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer.
|
Mol Cancer
|
2007
|
2.40
|
|
15
|
Oncogenic role of miR-483-3p at the IGF2/483 locus.
|
Cancer Res
|
2010
|
2.30
|
|
16
|
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
|
Cancer Res
|
2009
|
2.16
|
|
17
|
Modulation of mismatch repair and genomic stability by miR-155.
|
Proc Natl Acad Sci U S A
|
2010
|
2.05
|
|
18
|
MicroRNAs in human cancer: from research to therapy.
|
J Cell Sci
|
2007
|
2.00
|
|
19
|
MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis.
|
PLoS One
|
2009
|
1.97
|
|
20
|
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality.
|
Clin Cancer Res
|
2009
|
1.84
|
|
21
|
Karyotype-specific microRNA signature in chronic lymphocytic leukemia.
|
Blood
|
2009
|
1.70
|
|
22
|
Isolation and characterization of CD146+ multipotent mesenchymal stromal cells.
|
Exp Hematol
|
2008
|
1.68
|
|
23
|
Altered miRNA expression in T regulatory cells in course of multiple sclerosis.
|
J Neuroimmunol
|
2010
|
1.53
|
|
24
|
Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD.
|
Carcinogenesis
|
2010
|
1.52
|
|
25
|
Regulation of microRNA expression: the hypoxic component.
|
Cell Cycle
|
2007
|
1.49
|
|
26
|
Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas.
|
J Cell Physiol
|
2007
|
1.37
|
|
27
|
miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy.
|
J Pathol
|
2012
|
1.34
|
|
28
|
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model.
|
Hepatology
|
2012
|
1.23
|
|
29
|
Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
|
Int J Oncol
|
2009
|
1.11
|
|
30
|
miR-126&126* restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma.
|
PLoS One
|
2013
|
1.10
|
|
31
|
Mutated beta-catenin evades a microRNA-dependent regulatory loop.
|
Proc Natl Acad Sci U S A
|
2011
|
1.08
|
|
32
|
MicroRNAs dysregulation in human malignant pleural mesothelioma.
|
J Thorac Oncol
|
2011
|
1.06
|
|
33
|
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation.
|
Free Radic Biol Med
|
2008
|
0.99
|
|
34
|
Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule.
|
Mol Med
|
2013
|
0.95
|
|
35
|
Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.
|
Clin Cancer Res
|
2013
|
0.92
|
|
36
|
A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines.
|
Oncotarget
|
2013
|
0.89
|
|
37
|
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs.
|
Front Genet
|
2013
|
0.89
|
|
38
|
Tumor suppressor functions of ARLTS1 in lung cancers.
|
Cancer Res
|
2007
|
0.87
|
|
39
|
STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma.
|
Haematologica
|
2013
|
0.86
|
|
40
|
Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.
|
Mol Cancer
|
2013
|
0.86
|
|
41
|
Differential cytogenomics and miRNA signature of the Acute Myeloid Leukaemia Kasumi-1 cell line CD34+38- compartment.
|
Leuk Res
|
2010
|
0.85
|
|
42
|
Mesenchymal progenitors aging highlights a miR-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis.
|
Stem Cells
|
2015
|
0.84
|
|
43
|
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS).
|
PLoS One
|
2013
|
0.83
|
|
44
|
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients.
|
Oncotarget
|
2014
|
0.80
|
|
45
|
Non-coding RNAs change their expression profile after Retinoid induced differentiation of the promyelocytic cell line NB4.
|
BMC Res Notes
|
2010
|
0.79
|
|
46
|
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis.
|
Thromb Haemost
|
2014
|
0.78
|
|
47
|
Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes.
|
J Cell Physiol
|
2015
|
0.77
|
|
48
|
OncomiR detection in circulating body fluids: a PDMS microdevice perspective.
|
Lab Chip
|
2014
|
0.75
|